Pressreleases

Surgery Procedure Advancements to Fuel Future of CTR Systems to 2028

With increased awareness among patients suffering from carpal tunnel syndrome, apropos of carpal tunnel surgeries is projected to drive the global market for carpal tunnel release (CTR) systems over the forecast period of 2018-2028.

Rise in Opioid use for Pain Management Increases Revenues in North US Analgesics Market

By drug class, opioids are widely used analgesic drugs for treating moderate-to-severe pain such as pain caused by surgery, cancer, trauma, injury and other diseases.

Injectable Drug Delivery Market Revenue Expected to be Driven by Rising Prevalence of Chronic Diseases

According to the latest report published by Future Market Insights, titled ‘Global Injectable Drug Delivery Market: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the Global injectable drug delivery market is expected to expand at a compound annual growth rate (CAGR) of 10.9% over the 2018–2028 forecast period.

Future Market Insights – Global Canine Arthritis Treatment Market

Future Market Insights (FMI) delivers key insights on the global canine arthritis treatment market in its upcoming report titled “Canine Arthritis Treatment Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”.

Upcoming Pharmaceutical Courses from NSF

NSF has announced its upcoming courses. Make sure you remember to take advantage of any discounts you could be entitled to. Get in touch if you're interested in bringing any of this training on-site.

Meet NSF at the 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences

NSF has announced it will be exhibiting at the 2018 International Pharmaceutical Federation (FIP) World Congress in Glasgow, Scotland.

Future Market Insights – Growth of the Global Pneumococcal Vaccines Market

Future Market Insights (FMI) has delivered key insights on the global pneumococcal vaccines market in its upcoming report titled “Pneumococcal Vaccines Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”.

Novo Nordisk Pharmatech Enters Distribution Agreement with Signet Chemical Corporation

Novo Nordisk Pharmatech has entered an agreement with Signet Chemical Corporation for the distribution of its pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka.

Incident Management and Human Error Prevention Workshops

• Incident Management – 11 September 2018, Stansted, UK
• Human Error Prevention – 12-13 September 2018, Stansted, UK